These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 24927818)
1. Characterization of tau oligomeric seeds in progressive supranuclear palsy. Gerson JE; Sengupta U; Lasagna-Reeves CA; Guerrero-Muñoz MJ; Troncoso J; Kayed R Acta Neuropathol Commun; 2014 Jun; 2():73. PubMed ID: 24927818 [TBL] [Abstract][Full Text] [Related]
2. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640 [TBL] [Abstract][Full Text] [Related]
3. Neurofibrillary changes undergoing morphological and biochemical changes - How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain? Uchihara T Neuropathology; 2020 Oct; 40(5):450-459. PubMed ID: 32698244 [TBL] [Abstract][Full Text] [Related]
4. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity. Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611 [TBL] [Abstract][Full Text] [Related]
5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707 [TBL] [Abstract][Full Text] [Related]
6. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies. Uchihara T; Hara M; Nakamura A; Hirokawa K Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524 [TBL] [Abstract][Full Text] [Related]
7. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Yoshida M Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726 [TBL] [Abstract][Full Text] [Related]
8. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605 [TBL] [Abstract][Full Text] [Related]
9. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815 [TBL] [Abstract][Full Text] [Related]
10. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter. Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854 [TBL] [Abstract][Full Text] [Related]
11. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes. Lasagna-Reeves CA; Sengupta U; Castillo-Carranza D; Gerson JE; Guerrero-Munoz M; Troncoso JC; Jackson GR; Kayed R Acta Neuropathol Commun; 2014 May; 2():56. PubMed ID: 24887264 [TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Scaravilli T; Tolosa E; Ferrer I Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076 [TBL] [Abstract][Full Text] [Related]
14. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231 [TBL] [Abstract][Full Text] [Related]
15. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates. Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344 [TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. Sergeant N; Wattez A; Delacourte A J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497 [TBL] [Abstract][Full Text] [Related]
17. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains. Uchihara T; Nakamura A; Shibuya K; Yagishita S Brain Pathol; 2011 Mar; 21(2):180-8. PubMed ID: 20825412 [TBL] [Abstract][Full Text] [Related]
18. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892 [TBL] [Abstract][Full Text] [Related]
19. [Neuropathology of tauopathy]. Yoshida M Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931 [TBL] [Abstract][Full Text] [Related]
20. SUMO1 Modification of Tau in Progressive Supranuclear Palsy. Takamura H; Nakayama Y; Ito H; Katayama T; Fraser PE; Matsuzaki S Mol Neurobiol; 2022 Jul; 59(7):4419-4435. PubMed ID: 35567706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]